Disease: Hepatic encephalopathy

Modulation of gut microbiome in response to the combination of Escherichia coli Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiome

mycolabadmin

This study examined how a beneficial bacteria called Escherichia coli Nissle 1917 combined with different types of sugar affects gut bacteria. Researchers found that the effectiveness of these treatments depends heavily on each person’s unique starting microbiota composition, which is shaped by their diet, lifestyle, and health status. The results show that one-size-fits-all probiotic treatments don’t work equally for everyone, and doctors should personalize treatments based on an individual’s existing gut bacteria profile.

Read More »

Regulatory effects of Lycium Barbarum polysaccharides on immune function and their application prospects

mycolabadmin

Lycium barbarum, a plant used in traditional Chinese medicine for over 2000 years, contains special compounds called polysaccharides that boost the immune system. These compounds work by activating immune cells like macrophages and T cells, and can help fight infections and reduce inflammation. Research shows they may also help with conditions like arthritis, cancer, and gut health by acting as a natural prebiotic that promotes beneficial bacteria.

Read More »

Clinical significance and outcomes of adult living donor liver transplantation for acute liver failure: a retrospective cohort study based on 15-year single-center experience

mycolabadmin

Researchers studied 267 patients with acute liver failure over 15 years to compare two types of liver transplants: using living donors versus deceased donors. Living donor transplants worked just as well as deceased donor transplants, with similar patient survival rates, but allowed faster surgery before patients became critically ill. When a suitable living donor was available, performing the transplant quickly before severe brain complications developed led to better patient outcomes.

Read More »

Educational Case: Acetaminophen hepatotoxicity: Pathophysiology and evaluation of acute liver failure

mycolabadmin

This educational case describes how acetaminophen overdose causes severe liver damage leading to acute liver failure. The toxic form of acetaminophen damages liver cell mitochondria and causes widespread cell death, particularly in the center of liver lobules. Treatment with N-acetylcysteine within 24 hours of overdose significantly improves outcomes, though severe cases require liver transplantation.

Read More »

Therapeutic Plasma Exchange in Acute Liver Failure: A Real-World Study in Mexico

mycolabadmin

Acute liver failure is a serious medical emergency where the liver suddenly stops working properly. This study found that a treatment called therapeutic plasma exchange (TPE), which filters the blood to remove harmful substances, significantly improved survival rates in liver failure patients treated in a Mexican hospital. Patients receiving TPE had a 92% survival rate at 30 days compared to only 50% in those receiving standard treatment alone, even though the TPE group had more severe cases at the start.

Read More »

Increasing incidence of mycotoxicosis in South-Eastern Germany: a comprehensive analysis of mushroom poisonings at a University Medical Center

mycolabadmin

This study examined mushroom poisoning cases in a German hospital from 2005 to 2022 and found that poisonings have nearly doubled in recent years, likely due to more people foraging for wild mushrooms and changes in climate affecting mushroom distribution. The death cap mushroom (Amanita phalloides) caused the majority of serious cases, leading to liver and kidney failure. Researchers found that a blood-cleansing treatment called plasmapheresis could help stabilize patients with life-threatening bleeding complications while they recovered or waited for a liver transplant.

Read More »
Scroll to Top